Barbara Gayle Duncan Insider Trading $GNMX Aevi Genomic Medicine, LLC
Get free email notifications about insider trading for Barbara Gayle Duncan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Barbara Gayle Duncan. Barbara Gayle Duncan is Director in IMMUNOMEDICS INC ($IMMU) and Director in Innoviva, Inc. ($THRX) and CEO in Euthymics Bioscience Inc ($DOVP) and Director in Euthymics Bioscience Inc ($DOVP) and President and CFO in Euthymics Bioscience Inc ($DOVP) and Director in MEDGENICS, INC. ($MDGN) and Chief Accounting Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Chief Financial Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in Atea Pharmaceuticals, Inc. ($AVIR) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in Ovid Therapeutics Inc. ($OVID) and Director in Jounce Therapeutics, Inc. ($JNCE) and Director in Fusion Pharmaceuticals Inc. ($FUSN).
Barbara Gayle Duncan in Aevi Genomic Medicine, LLC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Barbara Gayle Duncan: Director
Holdings: 0 shares
Latest Transaction: Feb 05 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Barbara Gayle Duncan in Aevi Genomic Medicine, LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, GNMX, AVIR, DOVP, FUSN, IMMU, THRX, ICPT, JNCE, OVID
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | D | 2.84 | 10,591 | 30,078 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | D | 8.09 | 40,000 | 323,600 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | D | 4.83 | 20,000 | 96,600 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | D | 1.32 | 20,000 | 26,400 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | D | 1.55 | 50,000 | 77,500 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Sell | D | 0.00 | 59,524 | 0 | 0 | 59.5 K to 0 (-100.00 %) |
| Jun 18 2018 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | A | 1.55 | 50,000 | 77,500 | 50,000 | |
| Oct 18 2017 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | P | 2.84 | 10,591 | 30,078 | 10,591 | |
| Oct 18 2017 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Buy | P | 1.26 | 59,524 | 75,000 | 59,524 | 0 to 59.5 K |
| Aug 10 2017 | GNMX | Aevi Genomic Medic ... | Duncan Barbara Gayle | Director | Option Exercise | A | 1.32 | 20,000 | 26,400 | 20,000 | |
| Apr 19 2016 | MDGN | MEDGENICS, INC. | Duncan Barbara Gayle | Director | Option Exercise | A | 4.83 | 20,000 | 96,600 | 20,000 | |
| Jul 23 2015 | MDGN | MEDGENICS, INC. | Duncan Barbara Gayle | Director | Option Exercise | A | 8.09 | 20,000 | 161,800 | 20,000 |
Page: 1